RIYADH: A leading hematology patient advisory group based in Jazan has joined forces with a major biopharmaceutical company to brighten up the lives of young thalassemia patients.
Together, the Sheryan Society and Bristol Myers Squibb organized a unique puppet show to engage and entertain youngsters battling the blood disorder as part of the latter’s annual Global Patient Week in Saudi Arabia.
Khaled Dubaiyan Al-Dubaiyan, CEO of the Sheryan Association in Jazan, said: “The puppet show that we organized in cooperation with Bristol Myers Squibb brought a touch of magic to the lives of these children.
“The event was successful in reducing the burden of the hardships they face, drawing smiles on their faces and sparking a sense of joy in their hearts. We were pleased to cooperate with Bristol Myers Squibb for this event, a step that is of utmost importance in raising the morale of young thalassemia patients, and one that provided them with enhanced mental wellbeing and moral support.”
He added: “This initiative serves as an ideal example of an impactful corporate social responsibility effort, as it showcased that collaborations between the private and non-profit sectors can make a palatable difference in patients’ lives. More importantly, this initiative underscores the importance of supporting patients and providing them with comprehensive healthcare.”
Oscar Delgado, general manager for Bristol Myers Squibb in the Middle East and Africa, said: “Entering its tenth year, Global Patient Week has become a cornerstone of our culture, rekindling our commitment to our patients.
“Their profound experiences strengthen our resolve and align(ment) with Vision 2030 and the Kingdom’s Health Sector Transformation Program to build a vibrant society. This initiative supports our collective goal of advancing patient care through scientific innovation and contributing to the evolution of healthcare in the region.”
